Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-11-6
pubmed:abstractText
Further to a previous study whereby we reported that an in vitro emulsion of pirarubicin, amiodarone, and lipiodol was more stable and cytotoxic than a classic doxorubicin-lipiodol mixture, we designed a pilot study to evaluate efficacy and toxicity of a transarterial chemoembolization (TACE) procedure using a combination of pirarubicin, amiodarone, lipiodol, and gelatin sponge.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-453X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
238-44
pubmed:meshHeading
pubmed-meshheading:19349854-Aged, pubmed-meshheading:19349854-Aged, 80 and over, pubmed-meshheading:19349854-Amiodarone, pubmed-meshheading:19349854-Antineoplastic Agents, pubmed-meshheading:19349854-Carcinoma, Hepatocellular, pubmed-meshheading:19349854-Chemoembolization, Therapeutic, pubmed-meshheading:19349854-Doxorubicin, pubmed-meshheading:19349854-Female, pubmed-meshheading:19349854-Humans, pubmed-meshheading:19349854-Immunosuppressive Agents, pubmed-meshheading:19349854-Iodized Oil, pubmed-meshheading:19349854-Liver Neoplasms, pubmed-meshheading:19349854-Male, pubmed-meshheading:19349854-Middle Aged, pubmed-meshheading:19349854-Pilot Projects, pubmed-meshheading:19349854-Prognosis, pubmed-meshheading:19349854-Survival Rate, pubmed-meshheading:19349854-Tomography, X-Ray Computed, pubmed-meshheading:19349854-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
pubmed:affiliation
Departments of Interventional Radiology, University Hospital le Bocage, Dijon, France. boris.guiu@chu-dijon.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't